康宝莱中国区总经理蔡孟红。 受访者供图
随着减重药巨头诺和诺德重磅GLP-1类药物司美格鲁肽在中国的核心分子专利即将于3月到期，一大批中国本土的司美格鲁肽仿制药正在获批路上。据公开信息，目前国内市场上包括九源基因、丽珠集团、华东医药、齐鲁制药、正大天晴在内的十多家本土制药公司的司美格鲁肽仿制药有望在不久的将来上市，还有十余款处于三期临床，一场价格大战即将席卷。一位内分泌专家表示，随着更多仿制药的上市，减重药很快就会迎来“白菜价”时代。（第一财经）
，详情可参考WPS下载最新地址
p = p.next; // 指针后移，易错点2：忘记移动指针会导致死循环，更多细节参见旺商聊官方下载
Second, and more cleverly: he implemented a hash verification check on nozzle.js. The exact implementation could have been Subresource Integrity (SRI), a custom self-hashing routine, or a server-side nonce system, but the effect was the same. When the browser (or the application itself) loaded the script, it compared the modified file against a canonical hash and if it did not pass the check, the player would never initialise.